Delivery Order SPE2DB22D6029-SPE2DB24FU1UK

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,986.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Bacitracin 500 unit/GM Ophthalmic ointment in 3.5 GM tubes. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $6,930.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bacitracin 500 Unit/GM Ophthalmic Ointment, a pharmaceutical product used in medical care. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of May 23, 2024. There is no set-aside designation indicated for...
The U.S. Defense Logistics Agency (DLA) awarded a $4,278.83 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,564,911,404 units of 500 unit/gram bacitracin ophthalmic ointment. This order is part of Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
This federal contract award, with a ceiling value of $1,558.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of Bacitracin 500 Unit/GM Ophthalmic Ointment, 3.5GM, which is a critical pharmaceutical product used to treat eye infections. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 19, 2024. Amerisourcebergen, a major...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Bacitracin 500 Unit/GM Ophthalmic Ointment in 3.5 GM tubes. The contract, valued at $1,993.20, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,792.31, is for the supply of Bacitracin-Polymyxin Eye Ointment, a medical product used for eye care. The contract has a ceiling value of $5,792.31 and is a firm fixed-price delivery order running through March 4, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
The Defense Logistics Agency awarded a $471,360 firm fixed price delivery order to Amerisourcebergen Drug Corporation for bacitracin 500 unit/gram ophthalmic ointment. As part of its medical supply chain responsibilities, DLA issued this contract under a preexisting pharmaceuticals agreement to fulfill agency needs for this antibiotic ointment. Amerisourcebergen will deliver the specified 3.5 grams of bacitracin ointment to a Conshohocken, Pennsylvania facility by July 6, 2023 to support DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Bacitracin 500 unit/gm ointment in 28-gram packages. The contract has a total ceiling value of $2,824.70 and a period of performance through August 30, 2024. It is a firm fixed-price contract and was not set aside for a specific business category. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor and will be responsible for providing the medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of 4564676323 - Bacitracin 500 Unit/GM Ophth 3.5GM, a pharmaceutical product. The contract is a Delivery Order valued at $1,563.00 with a Firm Fixed Price pricing type. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to the Corporate Office division of Amerisourcebergen Drug Corp. The $2,325.40 Firm Fixed Price Delivery Order is for the supply of 4,564,683,031 units of Bacitracin 500 Unit/GM Ophthalmic Ointment, 3.5 GM, with a completion date of May 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a large...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB24FU1UK
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Bacitracin 500 Unit/gm Ophthalmic Ointment in 3.5 gm tubes. The contract has a firm fixed price of $1,645.71 and a performance period running through July 29, 2024. This award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:08 AM